Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists
K Kintzoglanakis, C Diamantis… - … & Vascular Disease …, 2024 - journals.sagepub.com
The newfound knowledge in type 2 diabetes (T2D) during the past decade for the sodium-
glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists …
glucose cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists …
Tirzepatide for overweight and obesity management
M Hamza, D Papamargaritis… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Tirzepatide is a once-weekly dual agonist, acting on glucagon-like peptide-1
(GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is approved at …
(GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It is approved at …
Effects of semaglutide on muscle structure and function in the SLIM liver study
Background Semaglutide is highly effective for decreasing weight. Concomitant loss of
muscle mass often accompanies weight loss and may have consequences on muscle …
muscle mass often accompanies weight loss and may have consequences on muscle …
Current Challenges, Solutions, and Novel Directions in Research and Clinical Care: Proceedings from the 14th Annual International Workshop on HIV and Aging
A Baim-Lance, S Cooley, M Yoo-Jeong… - The Journals of …, 2025 - academic.oup.com
Integrating antiretroviral therapy into HIV care dramatically extended the lifespan for people
living with HIV. Improving the health span requires understanding aging, HIV, associated …
living with HIV. Improving the health span requires understanding aging, HIV, associated …
Pharmacological management of pediatric metabolic dysfunction‐associated steatotic liver disease
RAR Abou Jaoudeh, P Hartmann… - Journal of pediatric …, 2024 - Wiley Online Library
Pediatric obesity, characterized by a body mass index (BMI) at or above the 95th percentile
for age, affects a substantial number of children and adolescents worldwide. Metabolic …
for age, affects a substantial number of children and adolescents worldwide. Metabolic …
Impact of exercise training in combination with dapagliflozin on physical function in adults with type 2 diabetes mellitus: study protocol for the Dapagliflozin, Exercise …
Introduction Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are associated with weight
loss, diverse cardiorenal benefits and improved glycaemic control. However, the effects of …
loss, diverse cardiorenal benefits and improved glycaemic control. However, the effects of …